title: [Pfizer's answer to Bengt Jarhult: joint challenge to develop methods for discovery of low-frequency adverse effects].
authors.affiliation: eva.dahl@pfizer.com
authors.forename: Eva
authors.initials: E
authors.lastname: Dahl
authors.forename: Gisela
authors.initials: G
authors.lastname: Lindstrand
mesh_terms: D004345:Drug Industry; D004346:Drug Information Services; D004335:Drug and Narcotic Control; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans